Synthetically accessible de novo design using reaction vectors: Application to PARP1 inhibitors

被引:1
|
作者
Ghiandoni, Gian Marco [1 ,8 ]
Flanagan, Stuart R. [2 ]
Bodkin, Michael J. [2 ]
Nizi, Maria Giulia [4 ]
Galera-Prat, Albert [5 ,6 ]
Brai, Annalaura [7 ]
Chen, Beining [3 ]
Wallace, James E. A. [2 ]
Hristozov, Dimitar [2 ]
Webster, James [1 ]
Manfroni, Giuseppe [4 ]
Lehtio, Lari [5 ,6 ]
Tabarrini, Oriana [4 ]
Gillet, Valerie J. [1 ,8 ]
机构
[1] Univ Sheffield, Informat Sch, Sheffield, England
[2] Evotec UK Ltd, Abingdon, England
[3] Univ Sheffield, Dept Chem, Dainton Bldg,13 Brook Hill, Sheffield S3 7HF, England
[4] Univ Perugia, Dept Pharmaceut Sci, I-06123 Perugia, Italy
[5] Univ Oulu, Fac Biochem & Mol Med, FI-90014 Oulu, Finland
[6] Univ Oulu, Bioctr Oulu, Oulu, Finland
[7] Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy
[8] Univ Sheffield, Informat Sch, Regent Court 211, Sheffield S1 4DP, England
基金
英国生物技术与生命科学研究理事会;
关键词
de novo drug design; PARP1; inhibitors; pharmaceuticals; reaction informatics; synthetic accessibility; SCREENING LIBRARIES; COMBINATION; PREDICTION; ALGORITHM; THERAPY; ASSAY;
D O I
10.1002/minf.202300183
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
De novo design has been a hotly pursued topic for many years. Most recent developments have involved the use of deep learning methods for generative molecular design. Despite increasing levels of algorithmic sophistication, the design of molecules that are synthetically accessible remains a major challenge. Reaction-based de novo design takes a conceptually simpler approach and aims to address synthesisability directly by mimicking synthetic chemistry and driving structural transformations by known reactions that are applied in a stepwise manner. However, the use of a small number of hand-coded transformations restricts the chemical space that can be accessed and there are few examples in the literature where molecules and their synthetic routes have been designed and executed successfully. Here we describe the application of reaction-based de novo design to the design of synthetically accessible and biologically active compounds as proof-of-concept of our reaction vector-based software. Reaction vectors are derived automatically from known reactions and allow access to a wide region of synthetically accessible chemical space. The design was aimed at producing molecules that are active against PARP1 and which have improved brain penetration properties compared to existing PARP1 inhibitors. We synthesised a selection of the designed molecules according to the provided synthetic routes and tested them experimentally. The results demonstrate that reaction vectors can be applied to the design of novel molecules of biological relevance that are also synthetically accessible. ** image
引用
收藏
页数:22
相关论文
共 50 条
  • [1] De novo design of synthetically accessible ligands.
    Johnson, AP
    Zsoldos, Z
    Baber, J
    Clark, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U689 - U689
  • [2] De novo design of synthetically accessible ligands.
    Johnson, AP
    Boda, K
    Marchaland, JF
    Ting, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U595 - U595
  • [3] de novo design of synthetically accessible molecules.
    Murray, CW
    Clark, DE
    Li, J
    Waszkowycz, B
    Westwood, DR
    Young, SC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 126 - COMP
  • [4] De novo design in the synthetically accessible compounds universe
    Lemmen, Christian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [5] De novo design using reaction vectors: Application to library design
    Gillet, Valerie J.
    Patel, Hina
    Bodkin, Michael
    Chen, Beining
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [6] De novo design of synthetically accessible compounds: Application to fragment-based drug design
    Gillet, Valerie J.
    Allen, Ben
    Bodkin, Michael
    Chen, Beining
    Cole, Jason
    Hristozov, Dimitar
    Liebeschuetz, John
    Patel, Hina
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [7] Improved methods for the de novo design of synthetically accessible ligands.
    Johnson, AP
    Boda, K
    Lengyel, T
    Weaver, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U509 - U509
  • [8] PARP1 Inhibitors: Antitumor Drug Design
    Malyuchenko, N. V.
    Kotova, E. Yu.
    Kulaeva, O. I.
    Kirpichnikov, M. P.
    Studitskiy, V. M.
    ACTA NATURAE, 2015, 7 (03): : 27 - 37
  • [9] RENATE: A Pseudo-retrosynthetic Tool for Synthetically Accessible de Novo Design
    Ghiandoni, Gian Marco
    Bodkin, Michael J.
    Chen, Beining
    Hristozov, Dimitar
    Wallace, James E. A.
    Webster, James
    Gillet, Valerie J.
    MOLECULAR INFORMATICS, 2022, 41 (04)
  • [10] Rational design and synthesis of new PARP1 inhibitors
    Romashov, Leonid V.
    Zeifman, Alexey A.
    Zakharenko, Alexandra L.
    Novikov, Fedor N.
    Stroilov, Viktor S.
    Stroganov, Oleg V.
    Chilov, Germes G.
    Khodyreva, Svetlana N.
    Lavrik, Olga I.
    Titov, Ilya Yu.
    Svitan'ko, Igor V.
    MENDELEEV COMMUNICATIONS, 2012, 22 (01) : 15 - 17